<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04948567</url>
  </required_header>
  <id_info>
    <org_study_id>KY20170119-2</org_study_id>
    <nct_id>NCT04948567</nct_id>
  </id_info>
  <brief_title>Efficacy of Split-dose of Oral MMS for Bowel Preparation in Elderly Patients</brief_title>
  <official_title>Efficacy of Split-dose of Oral Magnesium Sulfate Solution for Bowel Preparation in Elderly Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Air Force Military Medical University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Air Force Military Medical University, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adequate bowel preparation is critical for successful colonoscopy and a large volume of PEG&#xD;
      was required for bowel preparation in patients undergoing colonoscopy. The investigators&#xD;
      conducted a a prospective, randomized, controlled study to compare low dose of oral magnesium&#xD;
      sulfate solution with high dose PEG. The investigators found that patients who took low dose&#xD;
      of oral magnesium sulfate solution had similar bowel preparation quality to patients who took&#xD;
      PEG,but accompanied with fewer adverse events and better tolerance.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 30, 2017</start_date>
  <completion_date type="Actual">December 1, 2019</completion_date>
  <primary_completion_date type="Actual">December 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The rate of patients with adequate bowel preparation</measure>
    <time_frame>1 year</time_frame>
    <description>Defined by each segmental BBPSâ‰¥2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The rate of adenoma detection</measure>
    <time_frame>1 year</time_frame>
    <description>The proportion of participants with at least one adenoma in each group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the numbers of patients with adverse events</measure>
    <time_frame>1 year</time_frame>
    <description>eg. Vomiting, nausea, abdominal pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The cecal intubation rate</measure>
    <time_frame>1 year</time_frame>
    <description>The rate of colonoscopy reaching the cecum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The time of Cecal intubation</measure>
    <time_frame>during procedure</time_frame>
    <description>the time between the intubation and visualization of any of the following anatomic landmarks: ileocecal valve, appendiceal orifice, or terminal ileum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the time during Withdrawal phage</measure>
    <time_frame>during procedure</time_frame>
    <description>the inspection time from cecum to rectum</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1174</enrollment>
  <condition>Colonic Adenoma</condition>
  <condition>Bowel Preparation</condition>
  <arm_group>
    <arm_group_label>split-dose of Magnesium Sulfate solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Those assigned to MSS group were instructed to take 30ml of 50% magnesium sulfate solution and then drink 600ml water on the evening before colonoscopy. 70ml of 50% MMS and then 1500ml water was taken at least 4 hours before procedure on the colonoscopy day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>split-dose of PEG</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients in PEG group were instructed to take first dose of 1.5L PEG on the evening before colonoscopy and take the second dose of 1.5L PEG at least 4 hours before the colonoscopy procedure on the morning.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>split-dose of Magnesium Sulfate solution</intervention_name>
    <description>purgative for bowel preparation</description>
    <arm_group_label>split-dose of Magnesium Sulfate solution</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>split-dose of PEG</intervention_name>
    <description>purgative for bowel preparation</description>
    <arm_group_label>split-dose of PEG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients who underwent colonoscopy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  known or suspected bowel stricture or obstruction;&#xD;
&#xD;
          -  history of colorectal surgery;&#xD;
&#xD;
          -  significant gastroparesis or gastric outlet obstruction;&#xD;
&#xD;
          -  toxic colitis or megacolon;&#xD;
&#xD;
          -  severe acute inflammatory bowel disease;&#xD;
&#xD;
          -  active gastrointestinal bleeding;&#xD;
&#xD;
          -  suspected or confirmed chronic renal insufficiency and heart illness;&#xD;
&#xD;
          -  disturbance of electrolytes ;&#xD;
&#xD;
          -  unable to provide informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Endoscopic center, Xijing Hospital of Digestive Diseases</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Gastroenterology, The Second Medical Center &amp; National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital,</name>
      <address>
        <city>Beijing</city>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 27, 2021</study_first_submitted>
  <study_first_submitted_qc>June 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2021</study_first_posted>
  <last_update_submitted>June 24, 2021</last_update_submitted>
  <last_update_submitted_qc>June 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Air Force Military Medical University, China</investigator_affiliation>
    <investigator_full_name>Yanglin Pan</investigator_full_name>
    <investigator_title>associated professor</investigator_title>
  </responsible_party>
  <keyword>bowel preparation</keyword>
  <keyword>Oral magnesium sulfate solution</keyword>
  <keyword>polyethylene glycol solution</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

